Oral nomegestrol acetate and transdermal 17-beta-estradiol for preventing post-partum relapses in multiple sclerosis: The POPARTMUS study.

Sandra Vukusic,Iuliana Ionescu,Catherine Cornu,Nadine Bossard,Françoise Durand-Dubief,François Cotton,Luca Durelli,Romain Marignier,L. Gignoux,David-Axel Laplaud,Thibault Moreau,Pierre Clavelou,Jérôme De Seze,Marc Debouverie,David Brassat,Jean Pelletier,Christine Lebrun-Frenay,Emmanuelle Le Page,Giovanni Castelnovo,Eric Berger,Patrick Hautecoeur,Olivier Heinzlef,Maria Trojano,Francesco Patti,Etienne-Emile Baulieu,Laurent Remontet,Martine El-Etr

Oral nomegestrol acetate and transdermal 17-beta-estradiol for preventing post-partum relapses in multiple sclerosis: The POPARTMUS study.

2020

Background:Sex steroids could explain the course of multiple sclerosis (MS) in pregnancy.Objective:To compare the annualized relapse rate (ARR) 12 weeks post-partum in women treated with nomegestro...

Keywords:

Nomegestrol acetate
Gastroenterology
Transdermal
post partum
Multiple sclerosis
Internal medicine
17 beta estradiol
relapse rate
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations